These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9213214)

  • 41. Inhibitory effects of various L-type and T-type calcium antagonists on electrically generated, potassium-induced and carbachol-induced contractions of porcine detrusor muscle.
    Badawi JK; Li H; Langbein S; Kamp S; Guzman S; Bross S
    J Comp Physiol B; 2006 Jun; 176(5):429-39. PubMed ID: 16425017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different effects of calcium antagonists in a rat model of heart failure.
    Mulder P; Richard V; Thuillez C
    Cardiology; 1998; 89 Suppl 1():33-7. PubMed ID: 9570427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel.
    Schmitt R; Clozel JP; Iberg N; Bühler FR
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1161-5. PubMed ID: 7627710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
    Bezprozvanny I; Tsien RW
    Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Ro 40-5967, a novel calcium antagonist, on myocardial function during ischemia induced by lowering coronary perfusion pressure in dogs: comparison with verapamil.
    Clozel JP; Banken L; Osterrieder W
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):713-21. PubMed ID: 2481185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
    Brogden RN; Markham A
    Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential time course of the vasodilator action of various calcium antagonists.
    van der Lee R; Kam KL; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 1998; 12(6):607-12. PubMed ID: 9818292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of Ro 40-5967 and verapamil with the stably expressed alpha 1-subunit of the cardiac L-type calcium channel.
    Lacinová L; Welling A; Bosse E; Ruth P; Flockerzi V; Hofmann F
    J Pharmacol Exp Ther; 1995 Jul; 274(1):54-63. PubMed ID: 7616442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitory effect of mibefradil on contractions induced by sympathetic neurotransmitter release in the rat tail artery.
    van der Lee R; Pfaffendorf M; De Mey JG; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):74-9. PubMed ID: 10651150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The preferential inhibition of alpha 1- over beta-adrenoceptor-mediated positive inotropic effect by organic calcium antagonists in the rabbit papillary muscle.
    Kushida H; Hiramoto T; Endoh M
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):206-14. PubMed ID: 2160615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
    Nakaya H; Hattori Y; Nakao Y; Kanno M
    Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells.
    Barry WH; Horowitz JD; Smith TW
    Br J Pharmacol; 1985 May; 85(1):51-9. PubMed ID: 4027472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Negative inotropic effects of tiapamil (Ro11-1781) and verapamil in rabbit myocardium.
    Harada S; Sada H; Kojima M; Ban T
    Eur J Pharmacol; 1982 Feb; 78(1):7-14. PubMed ID: 7075665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different effects of calcium antagonists on fluid filtration of large arteries and albumin permeability in spontaneously hypertensive rats.
    Lacolley P; Poitevin P; Koen R; Levy BI
    J Hypertens; 1998 Mar; 16(3):349-55. PubMed ID: 9557928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antioxidant and cytoprotective activities of the calcium channel blocker mibefradil.
    Mason RP; Mak IT; Walter MF; Tulenko TN; Mason PE
    Biochem Pharmacol; 1998 Jun; 55(11):1843-52. PubMed ID: 9714303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of calcium-antagonistic coronary vasodilators, nifedipine and verapamil, on ventricular automaticity of the dog.
    Endoh M; Yanagisawa T; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Apr; 302(2):235-8. PubMed ID: 652065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential potentiation by depolarization of the effects of calcium antagonists on contraction and Ca2+ current in guinea-pig heart.
    Okuyama R; Adachi-Akahane S; Nagao T
    Br J Pharmacol; 1994 Oct; 113(2):451-6. PubMed ID: 7834195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative analysis of vascular to cardiac selectivity of L- and T-type voltage-operated calcium channel antagonists in human tissues.
    Angus JA; Sarsero D; Fujiwara T; Molenaar P; Xi Q
    Clin Exp Pharmacol Physiol; 2000 Dec; 27(12):1019-21. PubMed ID: 11117223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mibefradil: a new class of calcium-channel antagonists.
    Billups SJ; Carter BL
    Ann Pharmacother; 1998 Jun; 32(6):659-71. PubMed ID: 9640486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.